ArticleThe Journal of biological chemistry2026
Obscurin a localizes near the cell membrane to modulate stress fiber dynamics and cell migration.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Obscurin is a giant (720-900 kDa) modular cytoskeletal protein with multiple signaling domains. While it is most highly expressed in myocytes, obscurin is also the second most mutated protein in breast and colorectal cancers and is significantly downregulated in pancreatic cancer. Obscurin derives its antioncogenic properties, at least in part, through its ability to modulate cellular motility and migration; obscurin knockdown in cultured epithelial cells leads to increased migration and an epithelial-to-mesenchymal transition (EMT). Obscurin likely controls cell motility through the obscurin RhoGEF domain interaction with the RhoA/ROCK pathway and/or the obscurin PH domain interaction with a PI3K/PIP3 pathway. Here, we more fully describe which obscurin domains dictate subcellular localization and regulate cellular motility. The obscurin C-terminus adenovirally infected into MDCK and MCF - 10A cells localizes to adhesion structures at the plasma membrane. This localization is driven by four regions in obscurin: the obscurin RhoGEF and PH domains, along with two regions in the unstructured C-terminus. Infected cells lack central stress fibers, and this morphology is linked to the RhoGEF domain, the PH domain, and the C-terminal 76 residues. These three obscurin regions also inhibit cell motility. Together these data demonstrate how both specific obscurin domains and specific cellular localization regulate cellular velocity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.